Repurposing Tafenoquine as a Potential Inhibitor Against Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease via a Fluorescence Polarization Assay

ASSAY and Drug Development TechnologiesAhead of Print Letter to the Editor: Repurposing Tafenoquine as a Potential Inhibitor Against Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease via a Fluorescence Polarization AssayRui Zhang, Haohao Yan, Gangan Yan, Xiaoping Liu, and Yunyu ChenRui ZhangInstitute for Drug Screening and Evaluation, Wannan Medical College, Wuhu, China.*These authors are contributed equally to this work.Search for more papers by this author, Haohao Yanhttps://orcid.org/0009-0003-5174-320XInstitute for Drug Screening and Evaluation, Wannan Medical College, Wuhu, China.*These authors are contributed equally to this work.Search for more papers by this author, Gangan YanInstitute for Drug Screening and Evaluation, Wannan Medical College, Wuhu, China.Search for more papers by this author, Xiaoping LiuInstitute for Drug Screening and Evaluation, Wannan Medical College, Wuhu, China.Search for more papers by this author, and Yunyu ChenAddress correspondence to: Yunyu Chen, MD, Institute for Drug Screening and Evaluation, Wannan Medical College, Wuhu 241002, China E-mail Address: [email protected]https://orcid.org/0000-0002-2750-8221Institute for Drug Screening and Evaluation, Wannan Medical College, Wuhu, China.Search for more papers by this authorPublished Online:7 Nov 2023https://doi.org/10.1089/adt.2023.103AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 0Issue 0 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:Rui Zhang, Haohao Yan, Gangan Yan, Xiaoping Liu, and Yunyu Chen.Letter to the Editor: Repurposing Tafenoquine as a Potential Inhibitor Against Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease via a Fluorescence Polarization Assay.ASSAY and Drug Development Technologies.ahead of printhttp://doi.org/10.1089/adt.2023.103Online Ahead of Print:November 7, 2023PDF download